First Page | Document Content | |
---|---|---|
Date: 2013-07-25 21:28:57Chemistry Science Evaluation methods Pharmaceutical industry Pharmacology Clinical trial Maximum tolerated dose Phases of clinical research Dose-ranging study Clinical research Design of experiments Research | Microsoft Word - ctc-phase I and II trials.docAdd to Reading ListSource URL: www.ctc.usyd.edu.auDownload Document from Source WebsiteFile Size: 126,61 KBShare Document on Facebook |
PDF DocumentDocID: 17bs1 - View Document | |
Microsoft Word - ctc-phase I and II trials.docDocID: 14er6 - View Document | |
Full title: Dose finding clinical trial design for ordinal toxicity grades using the continuation ratio model: an extension of the continual reassessment methodDocID: zIK2 - View Document | |
ov ~p3 Syngenta Crop Protection, LLC P.O. Box[removed]Greensboro, NC[removed]DocID: ybWE - View Document | |
Package ‘bcrm’ July 2, 2014 Type Package Title Bayesian continual reassessment method (CRM) designs for Phase I dose-finding trials. Version[removed]Date[removed]DocID: xoUd - View Document |